152 related articles for article (PubMed ID: 12431663)
1. Significance of mycophenolate mofetil treatment in patients with HCV reinfection after liver transplantation: impact on clinical course and histologic damage.
Bahra M; Neumann UP; Harren M; Jacob D; Langrehr JM; Berg T; Neuhaus R; Neuhaus P
Transplant Proc; 2002 Nov; 34(7):2934-5. PubMed ID: 12431663
[No Abstract] [Full Text] [Related]
2. Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation.
Platz KP; Mueller AR; Willimski C; Mansoorian B; Berg T; Neuhaus R; Hopf U; Lobeck H; Neuhaus P
Transplant Proc; 1998 Jun; 30(4):1468-9. PubMed ID: 9636596
[No Abstract] [Full Text] [Related]
3. Indication for mycophenolate mofetil therapy in hepatitis C patients undergoing liver transplantation.
Platz KP; Mueller AR; Willimski C; Mansoorian B; Berg T; Neuhaus R; Hopf U; Radke C; Neuhaus P
Transplant Proc; 1998 Aug; 30(5):2232-3. PubMed ID: 9723453
[No Abstract] [Full Text] [Related]
4. Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetil.
Fasola CG; Netto GJ; Jennings LW; Christensen LL; Molmenti EP; Sanchez EQ; Levy MF; Goldstein RM; Klintmalm GB
Transplant Proc; 2002 Aug; 34(5):1563-4. PubMed ID: 12176486
[No Abstract] [Full Text] [Related]
5. Trough level-guided mycophenolate mofetil rejection prophylaxis in liver transplantation.
Grasser B; Iberer F; Schaffellner S; Kniepeiss D; Stauber R; Koshsorur G; Rehak P; Tscheliessnigg KH
Transplant Proc; 2001 May; 33(3):2154-6. PubMed ID: 11377484
[No Abstract] [Full Text] [Related]
6. Mycophenolate mofetil rescue therapy in liver transplant recipients.
Gavlik A; Goldberg MG; Tsaroucha A; Webb MG; Khan RT; Weppler D; Nery JR; Khan MF; Zucker K; Viciana AL; Miller JA; Tzakis AG
Transplant Proc; 1997; 29(1-2):549-52. PubMed ID: 9123124
[No Abstract] [Full Text] [Related]
7. Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation.
Nelson DR; Soldevila-Pico C; Reed A; Abdelmalek MF; Hemming AW; Van der Werf WJ; Howard R; Davis GL
Liver Transpl; 2001 Dec; 7(12):1064-70. PubMed ID: 11753908
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus.
Daly I; Jain A; Reyes J; Fung J
Transplant Proc; 2002 Aug; 34(5):1503. PubMed ID: 12176458
[No Abstract] [Full Text] [Related]
9. A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C.
Jain A; Kashyap R; Demetris AJ; Eghstesad B; Pokharna R; Fung JJ
Liver Transpl; 2002 Jan; 8(1):40-6. PubMed ID: 11799484
[TBL] [Abstract][Full Text] [Related]
10. Conversion from calcineurin inhibitors to mycophenolate mofetil in liver transplant recipients with diabetes mellitus.
Herrero JI; Quiroga J; Sangro B; Pardo F; Rotellar F; Cienfuegos JA; Prieto J
Transplant Proc; 2003 Aug; 35(5):1877-9. PubMed ID: 12962832
[TBL] [Abstract][Full Text] [Related]
11. Strategy for chronic rejection in recipient of living-related liver transplantation.
Koyamada N; Ohkohchi N; Doi H; Orii T; Kikuchi H; Chubachi S; Sekiguchi S; Kawagishi N; Haga I; Nakajima N; Satomi S; Oguma S
Transplant Proc; 2000 Nov; 32(7):2134-6. PubMed ID: 11120102
[No Abstract] [Full Text] [Related]
12. Indications for mycofenolate mofetil therapy after liver transplantation.
Platz KP; Mueller AR; Neuhaus P
Transplant Proc; 1997 Nov; 29(7):2880-1. PubMed ID: 9365601
[No Abstract] [Full Text] [Related]
13. Delay of hepatitis C recurrence in liver transplant recipients: impact of mycophenolate mofetil on transplant recipients with severe acute rejection or with renal dysfunction.
Fasola CG; Netto GJ; Christensen LL; Molmenti EP; Sanchez EQ; Levy MF; Goldstein RM; Klintmalm GB
Transplant Proc; 2002 Aug; 34(5):1561-2. PubMed ID: 12176485
[No Abstract] [Full Text] [Related]
14. FK 506 and mycofenolate mofetil rescue for acute steroid-resistant and chronic rejection after liver transplantation.
Platz KP; Mueller AR; Neuhaus R; Keck HH; Lobeck H; Neuhaus P
Transplant Proc; 1997 Nov; 29(7):2872-4. PubMed ID: 9365598
[No Abstract] [Full Text] [Related]
15. Mycophenolate mofetil rescue therapy in patients with chronic hepatic allograft rejection.
Kato T; Ruiz P; DeFaria W; Weppler D; Khan F; Pinna A; Nery J; Tzakis A
Transplant Proc; 1999; 31(1-2):396. PubMed ID: 10083158
[No Abstract] [Full Text] [Related]
16. Mycophenolate mofetil overlap in liver transplant recipients with chronic cyclosporine nephrotoxicity.
Torras J; Figueras J; Lama C; Fabregat J; Ramos E; Rafecas A; Gil-Vernet S; Pares D; Busquets J; Jaurrieta E
Transplant Proc; 1999 Sep; 31(6):2430. PubMed ID: 10500656
[No Abstract] [Full Text] [Related]
17. Indications for determination of alpha-glutathione-s-transferase after liver transplantation.
Platz KP; Mueller AR; Müller C; Wenig M; Schumacher G; Steinmüller T; Köttgen E; Neuhaus P
Transplant Proc; 1999; 31(1-2):462-4. PubMed ID: 10083191
[No Abstract] [Full Text] [Related]
18. Reversal of chronic rejection after treatment failure with FK506 and RS61443.
Roberts JP; Lake JR; Hebert M; Nikolai B; Ascher NL; Ferrell LD
Transplantation; 1993 Oct; 56(4):1021-3. PubMed ID: 7692634
[No Abstract] [Full Text] [Related]
19. Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations.
Jain A; Kashyap R; Kramer D; Dodson F; Hamad I; Starzl TE; Fung JJ
Transplant Proc; 2001; 33(1-2):1342-4. PubMed ID: 11267319
[No Abstract] [Full Text] [Related]
20. A prospective study comparing safety and efficacy of mycophenolate mofetil versus azathioprine in primary liver transplant recipients.
Fischer L; Sterneck M; Gahlemann CG; Malago M; Rogiers X; Broelsch CE
Transplant Proc; 2000 Nov; 32(7):2125-7. PubMed ID: 11120098
[No Abstract] [Full Text] [Related]
[Next] [New Search]
